About Dishman Carbogen Amcis Limited
Data last updated: 02 July 2026
Dishman Carbogen Amcis Limited is a public limited company based in Ahmedabad, Gujarat, India, a subsidiary of Adimans Technologies Llp. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 17 July 2007, the company has been in operation for over 19 years.
Registered with ROC Ahmedabad under CIN L74900GJ2007PLC051338. Listed on BSE: 540701 and NSE: DCAL.
Capital: an authorised share capital of ₹38 Cr and a paid-up capital of ₹31.36 Cr. It is led by directors including Deohooti Janmejay Vyas and Arpit Janmejay Vyas.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,733.18 Cr, a growth of 3% compared to the previous year.
It operates as a subsidiary of Adimans Technologies Llp. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands - Dishman Group, Dishman Carbogen Amcis. As per MCA filings, the company has open charges of ₹1,609.35 Cr and satisfied charges of ₹879.25 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dishmangroup.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressDishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited has one previous CIN (Corporate Identification Number): U74900GJ2007FLC051338. The current CIN is L74900GJ2007PLC051338, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74900GJ2007PLC051338 | Current |
| U74900GJ2007FLC051338 | Previous |
Associated Brands with Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited operates two associated brands: Dishman Group and Dishman Carbogen Amcis. These brands represent Dishman Carbogen Amcis Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| CDMO offering its services for the development of APIs and intermediates | dishmangroup.com | |
| Active pharmaceutical ingredients are manufactured by the CDMO in India. | imdcal.com |
Competitors & Alternatives of Dishman Carbogen Amcis Limited
Brands and companies operating in the same space as Dishman Carbogen Amcis Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is audited by T R CHADHA & CO. LLP (ICAI peer reviewed, certificate valid till 2028-09-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| T R CHADHA & CO. LLP (ICAI peer reviewed, certificate valid till 2028-09-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is currently managed by 8 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Deohooti Janmejay Vyas
Also directs:
Adimans Technologies Llp, B R Laboratories Limited, Dishman Biotech Limited and 5 more
|
Whole-Time Director | 17 Mar 2017 | 9 Years 3 Months | Current |
|
Arpit Janmejay Vyas
Also directs:
Dishman Biotech Limited, Rtv Technochem Private Limited, Leon Hospitality Private Limited and 5 more
|
Managing Director | 07 Apr 2012 | 14 Years 3 Months | Current |
| Dhaval Rameshchandra Shah | Director | 12 Aug 2025 | 0 Years 10 Months | Current |
|
Hemantkumar Jayantiprasad Bhatt
Also directs:
Transpek Creative Chemistry Private Limited
|
Director | 01 Apr 2025 | 1 Years 3 Months | Current |
| Margieben Sunil Parikh | Director | 01 Apr 2025 | 1 Years 3 Months | Current |
| Kulin Nalinkant Shah | Director | 13 Nov 2024 | 1 Years 7 Months | Current |
Financials of Dishman Carbogen Amcis Limited FY 2026 filings available
Dishman Carbogen Amcis Limited reported revenue of ₹2,931.9 Cr (up 8.13% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,931.9 Cr | ₹2,711.5 Cr | ₹2,615.77 Cr | ₹2,412.92 Cr | ₹2,140.69 Cr | ₹1,912.03 Cr | ₹2,043.6 Cr |
| Other Income | ₹55.94 Cr | ₹21.68 Cr | ₹28.21 Cr | ₹27.77 Cr | ₹43.42 Cr | ₹38.45 Cr | ₹44.46 Cr |
| Total Income | ₹2,987.84 Cr | ₹2,733.18 Cr | ₹2,643.98 Cr | ₹2,440.69 Cr | ₹2,184.11 Cr | ₹1,950.48 Cr | ₹2,088.06 Cr |
| Cost of Materials Consumed | ₹487.85 Cr | ₹592.96 Cr | ₹601.21 Cr | ₹624.99 Cr | ₹460.5 Cr | ₹421.86 Cr | ₹464.41 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹79.06 Cr | -₹91.31 Cr | -₹4.02 Cr | -₹113.58 Cr | -₹13.08 Cr | ₹46.29 Cr | -₹30.57 Cr |
| Employee Benefit Expense | ₹1,446.93 Cr | ₹1,293.57 Cr | ₹1,208.16 Cr | ₹1,035.27 Cr | ₹981.49 Cr | ₹872.91 Cr | ₹762.27 Cr |
| Finance Costs | ₹174.18 Cr | ₹159.46 Cr | ₹119.97 Cr | ₹85.69 Cr | ₹56.81 Cr | ₹47.61 Cr | ₹61.95 Cr |
| Depreciation & Amortisation | ₹338.69 Cr | ₹293.74 Cr | ₹310.86 Cr | ₹280.72 Cr | ₹307.59 Cr | ₹307.94 Cr | ₹282.87 Cr |
| Other Expenses | ₹510.55 Cr | ₹447.34 Cr | ₹523.92 Cr | ₹534.04 Cr | ₹380.41 Cr | ₹296.62 Cr | ₹325.05 Cr |
| Total Expenses | ₹2,879.14 Cr | ₹2,695.76 Cr | ₹2,760.1 Cr | ₹2,447.13 Cr | ₹2,173.72 Cr | ₹1,993.23 Cr | ₹1,865.98 Cr |
| Profit Before Exceptional Items & Tax | ₹108.7 Cr | ₹37.42 Cr | -₹116.12 Cr | -₹6.44 Cr | ₹10.39 Cr | -₹42.75 Cr | ₹222.08 Cr |
| Exceptional Items | -₹3.8 Cr | -₹18.11 Cr | -₹6.14 Cr | -₹48.15 Cr | -₹14.64 Cr | -₹22.28 Cr | ₹0 |
| Profit Before Tax | ₹104.9 Cr | ₹19.31 Cr | -₹122.26 Cr | -₹54.59 Cr | -₹4.25 Cr | -₹65.03 Cr | ₹222.08 Cr |
| Total Tax Expense | ₹7.45 Cr | ₹16.07 Cr | ₹31.19 Cr | -₹24.79 Cr | -₹22.26 Cr | ₹100.1 Cr | ₹41.78 Cr |
| Net Profit | ₹97.45 Cr | ₹3.24 Cr | -₹153.45 Cr | -₹29.8 Cr | ₹18.01 Cr | -₹165.13 Cr | ₹180.3 Cr |
| attributable to Owners | ₹97.45 Cr | ₹3.24 Cr | -₹153.45 Cr | -₹29.8 Cr | ₹18.01 Cr | -₹165.13 Cr | ₹180.3 Cr |
| attributable to NCI | ₹0 | - | ₹0 | - | - | ₹0 | ₹0 |
| Other Comprehensive Income | ₹747.92 Cr | ₹200.77 Cr | -₹28.75 Cr | ₹290.54 Cr | -₹164.2 Cr | ₹129.9 Cr | ₹210.86 Cr |
| Total Comprehensive Income | ₹845.37 Cr | ₹204.01 Cr | -₹182.2 Cr | ₹260.74 Cr | -₹146.19 Cr | -₹35.23 Cr | ₹391.16 Cr |
| EBITDA (computed) | ₹621.57 Cr | ₹490.62 Cr | ₹314.71 Cr | ₹359.97 Cr | ₹374.79 Cr | ₹312.8 Cr | ₹566.9 Cr |
| Basic EPS | ₹6.22 | ₹0.21 | ₹-9.79 | ₹-1.90 | ₹1.15 | ₹-10.53 | ₹11.20 |
| Diluted EPS | ₹6.22 | ₹0.21 | ₹-9.79 | ₹-1.90 | ₹1.15 | ₹-10.53 | ₹11.20 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹11,923 Cr | ₹9,999.15 Cr | ₹9,581.41 Cr | ₹9,453.5 Cr |
| Non-current Assets | ₹9,081.21 Cr | ₹7,798.73 Cr | ₹7,653.22 Cr | ₹7,535.14 Cr |
| Current Assets | ₹2,842.1 Cr | ₹2,200.42 Cr | ₹1,928.19 Cr | ₹1,918.36 Cr |
| Property, Plant & Equipment | ₹2,941.93 Cr | ₹2,683.86 Cr | ₹2,459.09 Cr | ₹1,960.93 Cr |
| Inventories | ₹1,019.12 Cr | ₹900.24 Cr | ₹882.89 Cr | ₹803.8 Cr |
| Trade Receivables | ₹672.91 Cr | ₹665.14 Cr | ₹461.11 Cr | ₹589.91 Cr |
| Cash & Equivalents | ₹787.76 Cr | ₹341.07 Cr | ₹264.09 Cr | ₹131.79 Cr |
| Equity (Net Worth) | ₹6,676.9 Cr | ₹5,831.52 Cr | ₹5,627.5 Cr | ₹5,809.67 Cr |
| Equity Share Capital | ₹31.36 Cr | ₹31.36 Cr | ₹31.36 Cr | ₹31.36 Cr |
| Borrowings (Non-current) | ₹1,534.86 Cr | ₹1,149.19 Cr | ₹245.61 Cr | ₹1,046.65 Cr |
| Borrowings (Current) | ₹1,240.54 Cr | ₹934.72 Cr | ₹1,718.79 Cr | ₹777.86 Cr |
| Total Debt (computed) | ₹2,775.4 Cr | ₹2,083.91 Cr | ₹1,964.4 Cr | ₹1,824.51 Cr |
| Current Liabilities | ₹2,317.05 Cr | ₹1,924.79 Cr | ₹2,554.72 Cr | ₹1,798.39 Cr |
| Total Liabilities | ₹5,246.41 Cr | ₹4,167.63 Cr | ₹3,953.91 Cr | ₹3,643.83 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹491.45 Cr | ₹375.23 Cr | ₹383.97 Cr | ₹220.34 Cr | ₹354.86 Cr |
| Investing Cash Flow | -₹245.34 Cr | -₹192.21 Cr | -₹229.52 Cr | -₹448.46 Cr | -₹618.53 Cr |
| Financing Cash Flow | ₹200.58 Cr | -₹102.09 Cr | -₹22.15 Cr | ₹249.67 Cr | ₹130.37 Cr |
| Capital Expenditure | ₹265.98 Cr | ₹216.76 Cr | ₹303.25 Cr | ₹574.06 Cr | ₹463.8 Cr |
| Free Cash Flow (computed) | ₹225.47 Cr | ₹158.47 Cr | ₹80.72 Cr | -₹353.72 Cr | -₹108.94 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹446.69 Cr | ₹76.98 Cr | ₹264.09 Cr | ₹21.55 Cr | -₹133.3 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹851.4 Cr | ₹719.8 Cr | ₹652.65 Cr | ₹708.05 Cr | ₹716.34 Cr | ₹682.34 Cr | ₹789.04 Cr | ₹523.78 Cr | ₹654.71 Cr | ₹651.09 Cr | ₹586.59 Cr | ₹723.38 Cr |
| Other Income | ₹16.42 Cr | ₹6.66 Cr | ₹8.11 Cr | ₹24.75 Cr | ₹7.97 Cr | ₹5.63 Cr | ₹6.65 Cr | ₹1.43 Cr | ₹7.16 Cr | ₹6.05 Cr | ₹8.47 Cr | ₹6.53 Cr |
| Total Income | ₹867.82 Cr | ₹726.46 Cr | ₹660.76 Cr | ₹732.8 Cr | ₹724.31 Cr | ₹687.97 Cr | ₹795.69 Cr | ₹525.21 Cr | ₹661.87 Cr | ₹657.14 Cr | ₹595.06 Cr | ₹729.91 Cr |
| Cost of Materials Consumed | ₹120.36 Cr | ₹127.79 Cr | ₹34.1 Cr | ₹205.6 Cr | ₹154.15 Cr | ₹161.58 Cr | ₹216.09 Cr | ₹61.14 Cr | ₹158.72 Cr | ₹202.53 Cr | ₹137.87 Cr | ₹102.09 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹14.55 Cr | ₹13.69 Cr | ₹21 Lakh | -₹107.51 Cr | -₹8.24 Cr | -₹62.75 Cr | -₹25.53 Cr | ₹5.21 Cr | ₹22.69 Cr | -₹84.41 Cr | -₹3.52 Cr | ₹61.22 Cr |
| Employee Benefit Expense | ₹406.21 Cr | ₹355.88 Cr | ₹332.94 Cr | ₹351.9 Cr | ₹324.94 Cr | ₹332.08 Cr | ₹319.73 Cr | ₹316.82 Cr | ₹320.77 Cr | ₹309.2 Cr | ₹283.06 Cr | ₹295.13 Cr |
| Finance Costs | ₹43.3 Cr | ₹45.79 Cr | ₹42.33 Cr | ₹42.76 Cr | ₹42.12 Cr | ₹48.78 Cr | ₹36.63 Cr | ₹31.93 Cr | ₹30.95 Cr | ₹33.08 Cr | ₹27.49 Cr | ₹28.45 Cr |
| Depreciation & Amortisation | ₹88.79 Cr | ₹84.42 Cr | ₹84.13 Cr | ₹81.35 Cr | ₹79.09 Cr | ₹71.97 Cr | ₹72.09 Cr | ₹70.59 Cr | ₹85 Cr | ₹80.37 Cr | ₹75.04 Cr | ₹70.45 Cr |
| Other Expenses | ₹147.33 Cr | ₹109.33 Cr | ₹136.51 Cr | ₹117.38 Cr | ₹92.8 Cr | ₹111.3 Cr | ₹131.6 Cr | ₹111.64 Cr | ₹89.85 Cr | ₹182.66 Cr | ₹108.33 Cr | ₹143.08 Cr |
| Total Expenses | ₹820.54 Cr | ₹736.9 Cr | ₹630.22 Cr | ₹691.48 Cr | ₹684.86 Cr | ₹662.96 Cr | ₹750.61 Cr | ₹597.33 Cr | ₹707.98 Cr | ₹723.43 Cr | ₹628.27 Cr | ₹700.42 Cr |
| Profit Before Exceptional Items & Tax | ₹47.28 Cr | -₹10.44 Cr | ₹30.54 Cr | ₹41.32 Cr | ₹39.45 Cr | ₹25.01 Cr | ₹45.08 Cr | -₹72.12 Cr | -₹46.11 Cr | -₹66.29 Cr | -₹33.21 Cr | ₹29.49 Cr |
| Exceptional Items | -₹1.15 Cr | ₹0 | ₹0 | -₹2.65 Cr | -₹11.75 Cr | ₹2.04 Cr | -₹2.96 Cr | -₹5.44 Cr | -₹3.09 Cr | ₹0 | -₹3.05 Cr | ₹0 |
| Profit Before Tax | ₹46.13 Cr | -₹10.44 Cr | ₹30.54 Cr | ₹38.67 Cr | ₹27.7 Cr | ₹27.05 Cr | ₹42.12 Cr | -₹77.56 Cr | -₹49.2 Cr | -₹66.29 Cr | -₹36.26 Cr | ₹29.49 Cr |
| Total Tax Expense | ₹24.39 Cr | ₹2.53 Cr | -₹34.73 Cr | ₹15.26 Cr | -₹15.39 Cr | ₹22.42 Cr | ₹9.03 Cr | ₹1 Lakh | ₹20.72 Cr | -₹6.66 Cr | ₹4.64 Cr | ₹12.49 Cr |
| Net Profit | ₹21.74 Cr | -₹12.97 Cr | ₹65.27 Cr | ₹23.41 Cr | ₹43.09 Cr | ₹4.63 Cr | ₹33.09 Cr | -₹77.57 Cr | -₹69.92 Cr | -₹59.63 Cr | -₹40.9 Cr | ₹17 Cr |
| attributable to Owners | ₹21.74 Cr | -₹12.97 Cr | ₹65.27 Cr | ₹23.41 Cr | ₹43.09 Cr | ₹4.63 Cr | ₹33.09 Cr | -₹77.57 Cr | -₹69.92 Cr | -₹59.63 Cr | -₹40.9 Cr | - |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | - | ₹0 | ₹0 | - | - | - |
| Other Comprehensive Income | ₹227.04 Cr | ₹76.12 Cr | ₹116.17 Cr | ₹328.59 Cr | ₹220.36 Cr | -₹173.33 Cr | ₹147.77 Cr | ₹5.97 Cr | -₹288.6 Cr | ₹274.77 Cr | -₹55.62 Cr | ₹40.7 Cr |
| Total Comprehensive Income | ₹248.78 Cr | ₹63.15 Cr | ₹181.44 Cr | ₹352 Cr | ₹263.45 Cr | -₹168.7 Cr | ₹180.86 Cr | -₹71.6 Cr | -₹358.52 Cr | ₹215.14 Cr | -₹96.52 Cr | ₹57.7 Cr |
| EBITDA (computed) | ₹179.37 Cr | ₹119.77 Cr | ₹157 Cr | ₹165.43 Cr | ₹160.66 Cr | ₹145.76 Cr | ₹153.8 Cr | ₹30.4 Cr | ₹69.84 Cr | ₹47.16 Cr | ₹69.32 Cr | ₹128.39 Cr |
| Basic EPS | ₹1.39 | ₹-0.83 | ₹4.16 | ₹1.49 | ₹2.75 | ₹0.30 | ₹2.11 | ₹-4.95 | ₹-4.46 | ₹-3.80 | ₹-2.61 | ₹1.08 |
| Diluted EPS | ₹1.39 | ₹-0.83 | ₹4.16 | ₹1.49 | ₹2.75 | ₹0.30 | ₹2.11 | ₹-4.95 | ₹-4.46 | ₹-3.80 | ₹-2.61 | ₹1.08 |
| Segment · FY 2022 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| CRAMS | ₹1,649.34 Cr | -₹26.58 Cr | - | - |
| OTHERS | ₹491.35 Cr | ₹68.79 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹231.56 Cr | ₹399.84 Cr | ₹327.35 Cr | ₹402.55 Cr | ₹302.79 Cr | ₹208.01 Cr | ₹580.74 Cr |
| Other Income | ₹84.52 Cr | ₹32.98 Cr | ₹63.05 Cr | ₹52.16 Cr | ₹65.71 Cr | ₹66.15 Cr | ₹69.55 Cr |
| Total Income | ₹316.08 Cr | ₹432.82 Cr | ₹390.4 Cr | ₹454.71 Cr | ₹368.5 Cr | ₹274.16 Cr | ₹650.29 Cr |
| Cost of Materials Consumed | ₹55.67 Cr | ₹117.01 Cr | ₹107.7 Cr | ₹163.35 Cr | ₹104.6 Cr | ₹86.54 Cr | ₹180.15 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹2.51 Cr | ₹0 | ₹0 |
| Changes in Inventories | -₹16.36 Cr | ₹14 Cr | ₹8.27 Cr | ₹8 Cr | -₹7.7 Cr | ₹21.9 Cr | ₹19.96 Cr |
| Employee Benefit Expense | ₹86.63 Cr | ₹90.15 Cr | ₹91.54 Cr | ₹86.13 Cr | ₹80.54 Cr | ₹59.4 Cr | ₹88.87 Cr |
| Finance Costs | ₹86.52 Cr | ₹70.4 Cr | ₹68.19 Cr | ₹57.92 Cr | ₹37.23 Cr | ₹34.17 Cr | ₹47.02 Cr |
| Depreciation & Amortisation | ₹62.57 Cr | ₹65.2 Cr | ₹101.61 Cr | ₹96.2 Cr | ₹140.07 Cr | ₹143.21 Cr | ₹140.65 Cr |
| Other Expenses | ₹100.3 Cr | ₹106.89 Cr | ₹113.04 Cr | ₹137.31 Cr | ₹88.65 Cr | ₹97.63 Cr | ₹118.18 Cr |
| Total Expenses | ₹375.33 Cr | ₹463.65 Cr | ₹490.35 Cr | ₹548.91 Cr | ₹445.9 Cr | ₹442.85 Cr | ₹594.83 Cr |
| Profit Before Exceptional Items & Tax | -₹59.25 Cr | -₹30.83 Cr | -₹99.95 Cr | -₹94.2 Cr | -₹77.4 Cr | -₹168.69 Cr | ₹55.46 Cr |
| Exceptional Items | ₹0 | ₹0 | -₹3.05 Cr | -₹2 Cr | -₹5.91 Cr | ₹0 | ₹0 |
| Profit Before Tax | -₹59.25 Cr | -₹30.83 Cr | -₹103 Cr | -₹96.2 Cr | -₹83.31 Cr | -₹168.69 Cr | ₹55.46 Cr |
| Total Tax Expense | -₹20.85 Cr | -₹20.96 Cr | -₹26.59 Cr | -₹37.33 Cr | -₹52.84 Cr | ₹64.12 Cr | ₹16.94 Cr |
| Net Profit | -₹38.4 Cr | -₹9.87 Cr | -₹76.41 Cr | -₹58.87 Cr | -₹31.55 Cr | -₹232.81 Cr | ₹38.52 Cr |
| Other Comprehensive Income | -₹109.86 Cr | -₹12.23 Cr | ₹14.69 Cr | -₹58.61 Cr | -₹407.61 Cr | ₹113.9 Cr | -₹94.94 Cr |
| Total Comprehensive Income | -₹148.26 Cr | -₹22.1 Cr | -₹61.72 Cr | -₹117.48 Cr | -₹439.16 Cr | -₹118.91 Cr | -₹56.42 Cr |
| EBITDA (computed) | ₹89.84 Cr | ₹104.77 Cr | ₹69.85 Cr | ₹59.92 Cr | ₹99.9 Cr | ₹8.69 Cr | ₹243.13 Cr |
| Basic EPS | ₹-2.45 | ₹-0.63 | ₹-4.87 | ₹-3.75 | ₹-2.01 | ₹-14.85 | ₹2.46 |
| Diluted EPS | ₹-2.45 | ₹-0.06 | ₹-4.87 | ₹-3.75 | ₹-2.01 | ₹-14.85 | ₹2.46 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹5,126.04 Cr | ₹5,122.35 Cr | ₹5,076.66 Cr | ₹5,181.04 Cr |
| Non-current Assets | ₹4,436.34 Cr | ₹4,447.37 Cr | ₹4,489.44 Cr | ₹4,531.43 Cr |
| Current Assets | ₹689.7 Cr | ₹674.98 Cr | ₹587.22 Cr | ₹649.61 Cr |
| Property, Plant & Equipment | ₹781.98 Cr | ₹798.17 Cr | ₹799.2 Cr | ₹727.12 Cr |
| Inventories | ₹155.12 Cr | ₹134.25 Cr | ₹169.62 Cr | ₹182.66 Cr |
| Trade Receivables | ₹170.62 Cr | ₹174.75 Cr | ₹183.7 Cr | ₹146.8 Cr |
| Cash & Equivalents | ₹15.93 Cr | ₹67.73 Cr | ₹4.05 Cr | ₹14.07 Cr |
| Equity (Net Worth) | ₹3,882.23 Cr | ₹4,030.48 Cr | ₹4,052.58 Cr | ₹4,114.31 Cr |
| Equity Share Capital | ₹31.36 Cr | ₹31.36 Cr | ₹31.36 Cr | ₹31.36 Cr |
| Borrowings (Non-current) | ₹123.86 Cr | ₹247.69 Cr | ₹157.37 Cr | ₹162.57 Cr |
| Borrowings (Current) | ₹506.76 Cr | ₹430.87 Cr | ₹366.61 Cr | ₹427.28 Cr |
| Total Debt (computed) | ₹630.62 Cr | ₹678.56 Cr | ₹523.98 Cr | ₹589.85 Cr |
| Current Liabilities | ₹868.9 Cr | ₹652.1 Cr | ₹618.73 Cr | ₹641.6 Cr |
| Total Liabilities | ₹1,243.81 Cr | ₹1,091.87 Cr | ₹1,024.08 Cr | ₹1,066.73 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹46.11 Cr | ₹55.81 Cr | ₹24.17 Cr | -₹52.9 Cr | ₹227.35 Cr |
| Investing Cash Flow | ₹21.68 Cr | -₹79.64 Cr | ₹96.57 Cr | ₹40.71 Cr | -₹172.67 Cr |
| Financing Cash Flow | -₹119.59 Cr | ₹87.51 Cr | -₹130.76 Cr | ₹1.38 Cr | -₹46.16 Cr |
| Capital Expenditure | ₹26.99 Cr | ₹54.9 Cr | ₹36.14 Cr | ₹123.24 Cr | ₹39 Cr |
| Free Cash Flow (computed) | ₹19.12 Cr | ₹91 Lakh | -₹11.97 Cr | -₹176.14 Cr | ₹188.35 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹51.8 Cr | ₹63.68 Cr | -₹10.02 Cr | -₹10.81 Cr | ₹8.52 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹68.72 Cr | ₹39.68 Cr | ₹60.3 Cr | ₹62.86 Cr | ₹106.1 Cr | ₹97.04 Cr | ₹93.29 Cr | ₹103.41 Cr | ₹111.26 Cr | ₹86.82 Cr | ₹59.72 Cr | ₹69.55 Cr |
| Other Income | ₹28.83 Cr | ₹7.1 Cr | ₹11.17 Cr | ₹37.42 Cr | ₹5.47 Cr | -₹8.01 Cr | ₹23.93 Cr | ₹11.59 Cr | -₹3.21 Cr | ₹13.11 Cr | ₹38.71 Cr | ₹14.44 Cr |
| Total Income | ₹97.55 Cr | ₹46.78 Cr | ₹71.47 Cr | ₹100.28 Cr | ₹111.57 Cr | ₹89.03 Cr | ₹117.22 Cr | ₹115 Cr | ₹108.05 Cr | ₹99.93 Cr | ₹98.43 Cr | ₹83.99 Cr |
| Cost of Materials Consumed | ₹13.35 Cr | ₹17.92 Cr | ₹11.19 Cr | ₹13.21 Cr | ₹22.75 Cr | ₹28.46 Cr | ₹33.55 Cr | ₹32.25 Cr | ₹26.48 Cr | ₹31.52 Cr | ₹27.1 Cr | ₹22.6 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹3.53 Cr | -₹19.11 Cr | ₹96 Lakh | -₹1.74 Cr | ₹9.74 Cr | -₹3.53 Cr | -₹1.46 Cr | ₹9.25 Cr | ₹14.04 Cr | ₹10.89 Cr | -₹20.85 Cr | ₹4.19 Cr |
| Employee Benefit Expense | ₹21.18 Cr | ₹21.43 Cr | ₹21.74 Cr | ₹22.28 Cr | ₹21.09 Cr | ₹23.43 Cr | ₹22.66 Cr | ₹22.97 Cr | ₹23.22 Cr | ₹23.55 Cr | ₹22.45 Cr | ₹22.32 Cr |
| Finance Costs | ₹22.14 Cr | ₹23.51 Cr | ₹20.61 Cr | ₹20.26 Cr | ₹21.31 Cr | ₹17.77 Cr | ₹15.59 Cr | ₹15.73 Cr | ₹15.87 Cr | ₹17.14 Cr | ₹17.42 Cr | ₹17.76 Cr |
| Depreciation & Amortisation | ₹15.15 Cr | ₹15.16 Cr | ₹15.79 Cr | ₹16.47 Cr | ₹16.1 Cr | ₹16.48 Cr | ₹16.3 Cr | ₹16.32 Cr | ₹26.12 Cr | ₹26.22 Cr | ₹24.58 Cr | ₹24.69 Cr |
| Other Expenses | ₹29.68 Cr | ₹22.94 Cr | ₹22 Cr | ₹25.68 Cr | ₹31.99 Cr | ₹25.72 Cr | ₹25.14 Cr | ₹24.04 Cr | ₹35.95 Cr | ₹17.69 Cr | ₹33.94 Cr | ₹25.46 Cr |
| Total Expenses | ₹105.03 Cr | ₹81.85 Cr | ₹92.29 Cr | ₹96.16 Cr | ₹122.98 Cr | ₹108.33 Cr | ₹111.78 Cr | ₹120.56 Cr | ₹141.68 Cr | ₹127.01 Cr | ₹104.64 Cr | ₹117.02 Cr |
| Profit Before Exceptional Items & Tax | -₹7.48 Cr | -₹35.07 Cr | -₹20.82 Cr | ₹4.12 Cr | -₹11.41 Cr | -₹19.3 Cr | ₹5.44 Cr | -₹5.56 Cr | -₹33.63 Cr | -₹27.08 Cr | -₹6.21 Cr | -₹33.03 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹3.05 Cr | ₹0 |
| Profit Before Tax | -₹7.48 Cr | -₹35.07 Cr | -₹20.82 Cr | ₹4.12 Cr | -₹11.41 Cr | -₹19.3 Cr | ₹5.44 Cr | -₹5.56 Cr | -₹33.63 Cr | -₹27.08 Cr | -₹9.26 Cr | -₹33.03 Cr |
| Total Tax Expense | -₹3.14 Cr | -₹11.94 Cr | -₹7.22 Cr | ₹1.45 Cr | -₹4.04 Cr | -₹6.02 Cr | -₹8.81 Cr | -₹2.09 Cr | -₹2.51 Cr | -₹8.9 Cr | -₹3.48 Cr | -₹11.7 Cr |
| Net Profit | -₹4.34 Cr | -₹23.13 Cr | -₹13.6 Cr | ₹2.67 Cr | -₹7.37 Cr | -₹13.28 Cr | ₹14.25 Cr | -₹3.47 Cr | -₹31.12 Cr | -₹18.18 Cr | -₹5.78 Cr | -₹21.33 Cr |
| Other Comprehensive Income | -₹54.88 Cr | -₹6.09 Cr | -₹18.63 Cr | -₹30.26 Cr | ₹65 Lakh | ₹5.18 Cr | -₹18.61 Cr | ₹55 Lakh | ₹39.63 Cr | -₹33.52 Cr | ₹2.33 Cr | ₹6.25 Cr |
| Total Comprehensive Income | -₹59.22 Cr | -₹29.22 Cr | -₹32.23 Cr | -₹27.59 Cr | -₹6.72 Cr | -₹8.1 Cr | -₹4.36 Cr | -₹2.92 Cr | ₹8.51 Cr | -₹51.7 Cr | -₹3.45 Cr | -₹15.08 Cr |
| EBITDA (computed) | ₹29.81 Cr | ₹3.6 Cr | ₹15.58 Cr | ₹40.85 Cr | ₹26 Cr | ₹14.95 Cr | ₹37.33 Cr | ₹26.49 Cr | ₹8.36 Cr | ₹16.28 Cr | ₹35.79 Cr | ₹9.42 Cr |
| Basic EPS | ₹-0.28 | ₹-1.47 | ₹-0.87 | ₹0.17 | ₹-0.47 | ₹-0.85 | ₹0.91 | ₹-0.22 | ₹-1.98 | ₹-1.16 | ₹-0.37 | ₹-1.36 |
| Diluted EPS | ₹-0.28 | ₹-1.47 | ₹-0.87 | ₹0.17 | ₹-0.47 | ₹-0.85 | ₹0.91 | ₹-0.22 | ₹-1.98 | ₹-1.16 | ₹-0.37 | ₹-1.36 |
| Segment · FY 2022 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| CRAMS | ₹0 | ₹0 | - | - |
| OTHERS | ₹0 | ₹0 | - | - |
Shareholding Pattern of Dishman Carbogen Amcis Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 59.32%, foreign institutional investors hold 7.45%, domestic institutional investors hold 1.63%, retail and other public shareholders hold 31.60% of Dishman Carbogen Amcis Limited. The company had 49,009 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% |
| Public | 40.68% | 40.68% | 40.68% | 40.68% | 40.68% | 40.68% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 63.17% | 61.40% | 61.40% |
| Public | 40.68% | 40.68% | 40.68% | 40.68% | 40.68% | 40.68% | 36.83% | 38.60% | 38.60% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | +0.00 | +0.00 | +0.00 | -3.85 | +1.77 | +0.00 | - |
Board & Governance of Dishman Carbogen Amcis Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Dishman Carbogen Amcis Limited has 6 directors - 3 independent and 2 executive.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Deohooti Janmejay Vyas | Executive Director | 2016-09-03 | 1 |
| Arpit Janmejay Vyas | Executive Director · MD | 2014-06-01 | 1 |
| Dhaval Rameshchandra Shah | Non-Executive - Non Independent Director | 2025-08-12 | 1 |
| Kulin Nalinkant Shah | Non-Executive - Independent Director | 2024-11-13 | 1 |
| Hemantkumar Jayantiprasad Bhatt | Non-Executive - Independent Director | 2025-04-01 | 1 |
| Margie Parikh | Non-Executive - Independent Director | 2025-04-01 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Hemantkumar Jayantiprasad Bhatt (Chairperson), Kulin Nalinkant Shah, Margie Parikh |
| Nomination and remuneration committee | Hemantkumar Jayantiprasad Bhatt (Chairperson), Kulin Nalinkant Shah, Margie Parikh |
| Stakeholders Relationship Committee | Hemantkumar Jayantiprasad Bhatt (Chairperson), Kulin Nalinkant Shah, Arpit Janmejay Vyas |
| Risk Management Committee | Arpit Janmejay Vyas (Chairperson), Harshil Ramakant Dalal, Hemantkumar Jayantiprasad Bhatt |
Group Structure of Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Dishman Carbogen Amcis Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Dishman Biotech Limited | U24231GJ1995PLC028060 | - |
| Dishman Medicare Limited (Formerly Known As Visible Investment Limited) | U65990GJ2021PLC122015 | - |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Dishman Carbogen Amcis Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2026 | Others | ₹42.85 Cr | Open |
| 30 Mar 2026 | Others | ₹60 Cr | Open |
| 10 Feb 2026 | Others | ₹75 Cr | Open |
| 17 Jan 2026 | Others | ₹50 Cr | Open |
| 13 Jan 2026 | Others | ₹20 Cr | Open |
Total charge records: 47 View all charges
Employees and EPFO Compliance at Dishman Carbogen Amcis Limited
View historical data on people associated with Dishman Carbogen Amcis Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Dishman Carbogen Amcis Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Dishman Carbogen Amcis Limited
GSTIN & GST Filing Data of Dishman Carbogen Amcis Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Dishman Carbogen Amcis Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Dishman Carbogen Amcis Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Dishman Carbogen Amcis Limited
MSME Payment Delays by Dishman Carbogen Amcis Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Dishman Carbogen Amcis Limited
Subsidiaries & Group Companies of Dishman Carbogen Amcis Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Dishman Carbogen Amcis Limited with ownership details.
MCA Filings & Documents of Dishman Carbogen Amcis Limited
MCA Filings & Documents of Dishman Carbogen Amcis Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Dishman Carbogen Amcis Limited
Recent News on Dishman Carbogen Amcis Limited
Frequently Asked Questions about Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 17 July 2007 (19+ years old) and is registered under CIN L74900GJ2007PLC051338. Listed on BSE: 540701 and NSE: DCAL.
Dishman Carbogen Amcis Limited reported revenue of ₹2,733.18 Cr for FY 2025 (up 3.00% YoY).
The current directors of Dishman Carbogen Amcis Limited are:
- Harshil Ramakant Dalal
- Shrima Gaurangbhai Dave
- Deohooti Janmejay Vyas
- Arpit Janmejay Vyas
- Dhaval Rameshchandra Shah
- Hemantkumar Jayantiprasad Bhatt
- Margieben Sunil Parikh
- Kulin Nalinkant Shah
The primary industry of Dishman Carbogen Amcis Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Dishman Carbogen Amcis Limited is listed on both BSE (code: 540701) and NSE (symbol: DCAL).
Dishman Carbogen Amcis Limited can be reached at the registered office: Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058, or through the website dishmangroup.com.